Effect of insulin-loaded trimethyl chitosan nanoparticles on genes expression in the hippocampus of diabetic rats

References

[1] Bastaki A. Review diabetes mellitus and its treatment. Int J Diabetes Metab 2005;13:111–34.10.1159/000497580Search in Google Scholar

[2] Kaparissides C, Alexandridou S, Kotti K, Chaitidou S. Recent advances in novel drug delivery systems. J Mater Online 2006;2:1–11.Search in Google Scholar

[3] Alai MS, Lin WJ, Pingale SS. Application of polymeric nanoparticles and micelles in insulin oral delivery. J Food Drug Anal 2015;23:351–8.10.1016/j.jfda.2015.01.007Search in Google Scholar PubMed

[4] Wong CY, Al-Salami H, Dass CR. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release 2017;264:247–75.10.1016/j.jconrel.2017.09.003Search in Google Scholar PubMed

[5] Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C. Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater Rev 2019;10:4.10.3390/jfb10010004Search in Google Scholar PubMed PubMed Central

[6] Reagan LP, Magarinos AM, McEwen BS. Neurological changes induced by stress in streptozotocin diabetic rats. Ann N Y Acad Sci 1999;893:126–37.10.1111/j.1749-6632.1999.tb07822.xSearch in Google Scholar PubMed

[7] Sima AAF, Li Z-g, Zhang W. The insulin-like growth factor system and neurological complications in diabetes. Exp Diabetes Res 2003;4:235–56.10.1155/EDR.2003.235Search in Google Scholar PubMed PubMed Central

[8] Cheng CM, Tseng V, Wang J, Wang D, Matyakhina L, Bondy CA. Tau is hyperphosphorylated in the insulin-like growth factor-I null brain. Endocrinology 2005;146:5086–91.10.1210/en.2005-0063Search in Google Scholar PubMed

[9] Crowder RJ, Freeman RS. Glycogen synthase kinase-3β activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 2000;275:34266–71.10.1074/jbc.M006160200Search in Google Scholar PubMed

[10] Hetman M, Cavanaugh JE, Kimelman D, Xia Z. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal. J Neurosci 2000;20:256–74.10.1523/JNEUROSCI.20-07-02567.2000Search in Google Scholar

[11] Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, Heidenreich KA. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β. Mol Cell Biol 2000;20:9356–63.10.1128/MCB.20.24.9356-9363.2000Search in Google Scholar PubMed PubMed Central

[12] Tong N, Sanchez JF, Maggirwar SB, Ramirez SH, Guo H, Dewhurst S, et al. Activation of glycogen synthase kinase 3β (GSK-3β) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 2001;13:1913–22.10.1046/j.0953-816x.2001.01572.xSearch in Google Scholar PubMed

[13] Janssen JA, Lamberts SW. Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clin Endocrinol (Oxf) 2000;52:1–9.10.1046/j.1365-2265.2000.00922.xSearch in Google Scholar PubMed

[14] Hu Q, Luo YC. Recent advances of polysaccharide-based nanoparticles for oral insulin delivery. Int J Biol Macromol 2018;120:775–82.10.1016/j.ijbiomac.2018.08.152Search in Google Scholar PubMed

[15] Muzzarelli RA. Chitin. Oxford, UK: Pergamon Press, 1977.Search in Google Scholar

[16] Muzzarelli RA. Chitosan chemistry: relevance to the biomedical sciences. Polysaccharides 2005;186:151–209.10.1007/b136820Search in Google Scholar

[17] Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 2007;59:24–34.10.1016/j.colsurfb.2007.04.009Search in Google Scholar PubMed

[18] Mahjub R, Dorkoosh FA, Amini M, Khoshayand MR, Rafiee-Tehrani M. Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech 2011;12:1407–19.10.1208/s12249-011-9716-9Search in Google Scholar PubMed PubMed Central

[19] Ma Z, Lim TM, Lim LY. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm 2005;293:271–80.10.1016/j.ijpharm.2004.12.025Search in Google Scholar PubMed

[20] Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 2009;30:2329–39.10.1016/j.biomaterials.2008.12.066Search in Google Scholar PubMed

[21] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔC(T)) method. Methods 2001;25:402–8.10.1006/meth.2001.1262Search in Google Scholar PubMed

[22] Kalantarian G, Ziamajidi N, Mahjub R, Goodarzi MT, Saidijam M, Soleimani Asl S, et al. Effect of insulin-loaded trimethyl chitosan nanoparticles on IGF-1, IGF-2, and apoptosis in the hippocampus of diabetic male rats. Restor Neurol Neurosci 2018;36:571–81.10.3233/RNN-170807Search in Google Scholar

[23] Zhuang HX, Wuarin L, Fei ZJ, Ishii DN. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy. J Pharmacol Exp Ther 1997;283:366–74.Search in Google Scholar

[24] Song W, Jiang W, Wang C, Xie J, Liang X, Sun Y, et al. Jinmaitong, a traditional Chinese compound prescription, ameliorates the streptozotocin-induced diabetic peripheral neuropathy rats by increasing sciatic nerve IGF-1 and IGF-1R expression. Front Pharmacol 2019;10:255.10.3389/fphar.2019.00255Search in Google Scholar PubMed PubMed Central

[25] Jamali R, Bao M, Arnqvist H. IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells. J Endocrinol 2003;179:267–74.10.1677/joe.0.1790267Search in Google Scholar

[26] Kangmao H, Yanyan C, Rui Z, Yizheng W, Yan M, Xiangqian F, et al. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis 2018;9:157.10.1038/s41419-017-0166-5Search in Google Scholar

[27] Fernandez M, Sanchez-Franco F, Palacios N, Sanchez I, Fernandez C, Cacicedo L. IGF-I inhibits apoptosis through the activation of the phosphatidylinositol 3-kinase/Akt pathway in pituitary cells. J Mol Endocrinol 2004;33:155–60.10.1677/jme.0.0330155Search in Google Scholar

[28] Li ZG, Zhang W, Grunberger G, Sima AA. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 2002;946:221–31.10.1016/S0006-8993(02)02887-1Search in Google Scholar

[29] Gómez RL, Edgin JO. The extended trajectory of hippocampal development: implications for early memory development and disorder. Dev Cognit Neurosci 2016;18:57–69.10.1016/j.dcn.2015.08.009Search in Google Scholar PubMed PubMed Central

[30] Hui L, Pei DS, Zhang QG, Guan QH, Zhang GY. The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation. Brain Res 2005;1052:1–9.10.1016/j.brainres.2005.05.043Search in Google Scholar PubMed

[31] Stern SA, Chen DY, Alberini CM. The effect of insulin and insulin-like growth factors on hippocampus- and amygdala-dependent long-term memory formation. Learn Memory 2014;21:556–63.10.1101/lm.029348.112Search in Google Scholar PubMed PubMed Central

[32] Sung HW, Sonaje K, Liao Z-X, Hsu LW, Chuang E-Y. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications. Acc Chem Res 2012;45:619–29.10.1021/ar200234qSearch in Google Scholar PubMed